Clinical evaluation of a new laser‐ablated titanium implant for bone‐anchored hearing in 34 patients: 1‐year experience

Clinical evaluation of a new laser‐ablated titanium implant for bone‐anchored hearing in 34... KeypointsIn specific patient groups with a bone conduction hearing implant, ie children or patients with compromised bone quality, the incidence of implant loss is much higher; further implant optimisation is, therefore, needed.The new laser‐ablated titanium implant for bone‐anchored hearing implantation has an enlarged contact area for osseointegration compared to the standard implant, aiming to improve implant loss rates.This retrospective multicentre study is the first to assess the performance of this implant in healthy adults 1 year after surgery.With excellent survival rates, good soft tissue tolerability and few complications, the implant is safe to use in healthy adults.INTRODUCTIONSuccessful bone‐anchored hearing implantation requires good osseointegration of the titanium implant in the temporal bone and low skin‐related complication rates. The introduction of wider diameter implants, providing an enlarged bone‐implant interface and thus a larger interface for osseointegration, has resulted in up to 3‐year survival rates of >96% in healthy adult patients. Despite the low incidence of implant loss in healthy adults, in certain patient groups, ie patients with compromised bone quality or in children, the incidence is much higher, varying between 3.5%‐10.5% even with these wider diameter implants. To improve implant survival in these populations as well, further optimisation of implant material, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Otolaryngology Wiley

Clinical evaluation of a new laser‐ablated titanium implant for bone‐anchored hearing in 34 patients: 1‐year experience

Loading next page...
 
/lp/wiley/clinical-evaluation-of-a-new-laser-ablated-titanium-implant-for-bone-zn7be0ZUej
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 John Wiley & Sons Ltd
ISSN
1749-4478
eISSN
1749-4486
D.O.I.
10.1111/coa.13060
Publisher site
See Article on Publisher Site

Abstract

KeypointsIn specific patient groups with a bone conduction hearing implant, ie children or patients with compromised bone quality, the incidence of implant loss is much higher; further implant optimisation is, therefore, needed.The new laser‐ablated titanium implant for bone‐anchored hearing implantation has an enlarged contact area for osseointegration compared to the standard implant, aiming to improve implant loss rates.This retrospective multicentre study is the first to assess the performance of this implant in healthy adults 1 year after surgery.With excellent survival rates, good soft tissue tolerability and few complications, the implant is safe to use in healthy adults.INTRODUCTIONSuccessful bone‐anchored hearing implantation requires good osseointegration of the titanium implant in the temporal bone and low skin‐related complication rates. The introduction of wider diameter implants, providing an enlarged bone‐implant interface and thus a larger interface for osseointegration, has resulted in up to 3‐year survival rates of >96% in healthy adult patients. Despite the low incidence of implant loss in healthy adults, in certain patient groups, ie patients with compromised bone quality or in children, the incidence is much higher, varying between 3.5%‐10.5% even with these wider diameter implants. To improve implant survival in these populations as well, further optimisation of implant material,

Journal

Clinical OtolaryngologyWiley

Published: Jan 1, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off